Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001622240-17-000001
Filing Date
2017-03-17
Accepted
2017-03-17 14:34:05
Documents
1
Effectiveness Date
2017-03-17
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 12393
  Complete submission text file 0001622240-17-000001.txt   13438
Mailing Address SUITE #430, 580 HORNBY STREET VANCOUVER A1 V6C 3B6
Business Address SUITE #430, 580 HORNBY STREET VANCOUVER A1 V6C 3B6 604-674-2191
Supreme Pharmaceuticals Inc. (Filer) CIK: 0001622240 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-282836 | Film No.: 17697501